Basics MIMEDX GROUP INC MiMedx Group Inc is a developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. IPO Date: March 1, 2008 Sector: Healthcare Industry: Biotech Market Cap: $1.03B Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 2.47% Avg Daily Range (30 D): $0.17 | 2.35% Avg Daily Range (90 D): $0.13 | 1.80% Institutional Daily Volume Avg Daily Volume: .76M Avg Daily Volume (30 D): .87M Avg Daily Volume (90 D): .63M Trade Size Avg Trade Size (Sh.): 144 Avg Trade Size (Sh.) (30 D): 87 Avg Trade Size (Sh.) (90 D): 83 Institutional Trades Total Inst.Trades: 2,047 Avg Inst. Trade: $1.4M Avg Inst. Trade (30 D): $.86M Avg Inst. Trade (90 D): $.94M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.49M Avg Closing Trade (30 D): $.87M Avg Closing Trade (90 D): $.88M Avg Closing Volume: 176.14K     News Oct 15, 2025 @ 12:00 PM MIMEDX to Host Third Quarter 2025 Operating and Fi... Source: Matt Notarianni Sep 3, 2025 @ 12:00 PM MIMEDX to Sponsor and Attend Symposium on Advanced... Source: Matt Notarianni Feb 12, 2025 @ 12:00 PM MediWound Initiates the VALUE Global Phase III Piv... Source: N/A Nov 26, 2024 @ 11:47 AM Chronic Wound Care Market to Expand at a Modest 4.... Source: Globe Newswire Oct 8, 2024 @ 8:01 PM MIMEDX Points to The New York Times Article on the... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $.21 $.07 $.05 Diluted EPS $.21 $.06 $.05 Revenue $ 363.77M $ 98.61M $ 88.21M Gross Profit $ 296.3M $ 79.92M $ 71.65M Net Income / Loss $ 32.17M $ 9.62M $ 7.02M Operating Income / Loss $ 42.84M $ 12.37M $ 8.25M Cost of Revenue $ 67.47M $ 18.68M $ 16.56M Net Cash Flow $ 49.83M $ 12.44M $ 2.02M PE Ratio 32.81     Splits Apr 02, 2008:   11:34